Timely Diagnosis of Myeloma in Populations with Comorbidities and Health Disparities: Testing Considerations

Join a comprehensive webinar led by distinguished experts Dr. Joseph Mikhael and Dr. Christopher Farnsworth exploring the critical aspects of diagnosing plasma cell dyscrasias (PCDs), with a special focus on Multiple Myeloma in populations affected by health disparities. Learn about the various testing methods required for accurate screening, including serum protein electrophoresis (SPEP), serum and urine immunofixation (IFE), and serum free light chain assays. Examine healthcare disparities contributing to delayed diagnoses in Black/African American and Hispanic communities, and discover insights from a comparative study of two serum free light chain assays conducted on 176 patients with comorbidities. Master the analytical considerations of test panels, understand clinical implications of result sensitivity and specificity, and develop a rational approach to testing for plasma cell disorders in diverse populations. Gain valuable knowledge about the importance of targeted screening in high-risk communities while earning PACE credits through this hour-long educational session.